Phospho-PTEN (Ser380/Thr382/383) (Clone: E4) rabbit mAb
Fig-1: Western blot analysis of HEK293 cell extract untreated or treated with lambda phosphatase using Phospho-PTEN (Ser380/Thr382/383) antibody PTENS380T382383-E4. Concentration 0.01 µg/mL.
Roll over image to zoom in
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
Format : | Purified |
Amount : | 200 µl |
Isotype : | Rabbit IgG1k |
Content : | 1X PBS, 0.02% NaN3, 50% Glycerol, 0.1% BSA |
Storage condition : | Store at -20°C. Avoid repeated freeze and thaw cycles. |
Alternative Name : | Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase, Mutated in multiple advanced cancers 1, MMAC1, Phosphatase and tensin homolog, TEP1 |
Immunogen Information : | A synthetic phospho-peptide corresponding to residues surrounding Ser380 and Thr382/383 of human phospho PTEN |
PTEN has been identified as a tumor suppressor gene and has been found to be mutated in a significant number of human cancers, including prostate, brain, and breast cancer. PTEN shares sequence homology with the protein-tyrosine phosphatase (PTPase) family of proteins and negatively regulates the PI3K/Akt pathway. PTEN de-phosphorylates target proteins, and recombinant PTEN has been shown to have phosphoinositide 3-phosphhatase and inositol phosphate 3-phosphatase activity. Studies of primary tumor cells show a loss of PTEN expression after metastasis to the brain, via astrocyte-derived microRNAs. A cluster of phosphorylation sites (S380, T382, T383, and S385) in the C-terminal tail of PTEN drive a conformational change that reduces PTEN activity by inhibiting membrane interactions.
1µg/mL - 0.001µg/mL. It is recommended that the reagent be titrated for optimal performance for each application. See product image legends for additional information.(0.5mg/ml, more than 200 western blots)
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
There are currently no product reviews
|